Increasing complexity: which drug class to choose for treatment of hypertension in the elderly?

References

• SimpsonFOLong-term cost and life-expectancy consequences of hypertensionJ Hypertens1998168109911009794710
   PubMed Web of Science ®Google Scholar
• PimentaEOparilSManagement of hypertension in the elderlyNat Rev Cardiol20129528629622411292
   PubMed Web of Science ®Google Scholar
• Statistisches BundesamtBevölkerung Deutschlands bis 2060 12 koordinierte Bevölkerungsvorausberechnung [German population up to 2060 12 Coordinated population projection]2009 Available from https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/Vorausberech-nungBevoelkerung/BevoelkerungDeutschland2060Presse5124204099004.pdf?__blob=publicationFileAccessed February 20, 2014
   Google Scholar
• AronowWSFlegJLPepineCJACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of HypertensionJ Am Soc Hypertens20115425935221771565
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczKTask Force Members2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20133171281135723817082
   PubMed Web of Science ®Google Scholar
• GueyffierFBulpittCBoisselJPAntihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA GroupLancet1999353915579379610459960
   PubMed Web of Science ®Google Scholar
• PetersRBeckettNPoulterRKidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trialAge Ageing201342225325822910302
   PubMed Web of Science ®Google Scholar
• MutasingwaDRGeHUpshurREHow applicable are clinical practice guidelines to elderly patients with comorbidities?Can Fam Physician2011577e253e26221753084
   PubMed Web of Science ®Google Scholar
• GhaliJKKadakiaSCooperRFerlinzJPrecipitating factors leading to decompensation of heart failure. Traits among urban blacksArch Intern Med19881489201320163046541
   PubMedGoogle Scholar
• SchäferHHSudanoITheusGRZillaPNollGBurnierMBlood pressure target attainment in the background of guidelines: the very elderly in Swiss primary careFam Pract201229551152022379186
   PubMed Web of Science ®Google Scholar
• BorzeckiAMOliveriaSABerlowitzDRBarriers to hypertension controlAm Heart J2005149578579415894958
   PubMed Web of Science ®Google Scholar
• HajjarIMillerKHirthVAge-related bias in the management of hypertension: a national survey of physicians’ opinions on hypertension in elderly adultsJ Gerontol A Biol Sci Med Sci2002578M487M49112145360
   PubMed Web of Science ®Google Scholar
• Rodriguez-RocaGCLlisterriJLPrieto-DiazMABlood pressure control and management of very elderly patients with hypertension in primary care settings in SpainHypertens Res201437216617124089262
   PubMed Web of Science ®Google Scholar
• JamesPAOparilSCarterBL2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (JNC 8)JAMA2014311550752024352797
   PubMed Web of Science ®Google Scholar
• WoodSJNC 8 at Last! Guidelines Ease Up on BP Thresholds, Drug ChoicesHeartwire2013 http://www.medscape.com/viewarticle/817991Accessed February 17, 2014
   Google Scholar
• SoxHCAssessing the trustworthiness of the guideline for management of high blood pressure in adultsJAMA2014311547247424352688
   PubMed Web of Science ®Google Scholar
• BauchnerHFontanarosaPBGolubRMUpdated guidelines for management of high blood pressure: recommendations, review, and responsibilityJAMA2014311547747824352759
   PubMed Web of Science ®Google Scholar
• PetersonEDGazianoJGreenlandPRecommendations for treating hypertension: What are the right goals and purposes?JAMA2013
   Web of Science ®Google Scholar
• WeberMASchiffrinELWhiteWBClinical Practice Guidelines for the Management of Hypertension in the CommunityThe Journal of Clinical Hypertension2014161142624341872
   PubMed Web of Science ®Google Scholar
• WoodSHypertension Guidelines: But Wait, There’s MoreHeartwire2014 http://www.medscape.com/viewarticle/818652Accessed February 17, 2014
   Google Scholar
• GoASBaumanMKingSMCAn Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and PreventionHypertension Epub11152013
   Web of Science ®Google Scholar
• O’RiordanMAHA/ACC/CDC Issue ‘Science Advisory’ on Treating BPHeartwire2013 http://content.onlinejacc.org/article.aspx?articleid=1778408Accessed February 17, 2014
   Google Scholar
• FriedenTRKingSWrightJSProtocol-based treatment of hypertension: A critical step on the pathway to progressJAMA20143111212224231925
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceNICE clinical guideline 127. Hypertension: clinical management of primary hypertension in adultsLondonNational Institute for Health and Clinical Excellence2011 Available from: http://www.nice.org.uk/nicemedia/live/13561/56008/56008.pdfAccessed February 13, 2014
   Google Scholar
• ChobanianAVBakrisGLBlackHRNational Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA2003289192560257212748199
   PubMed Web of Science ®Google Scholar
• HouleSKPadwalRTsuyukiRTThe 2012–2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An updateCan Pharm J (Ott)2013146314615023795198
   PubMedGoogle Scholar
• KjeldsenSEJuliusSHypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersAm Heart J2004148574775415523303
   PubMed Web of Science ®Google Scholar
• BriasoulisAAgarwalVTousoulisDStefanadisCEffects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studiesHeart2014100431732323813846
   PubMed Web of Science ®Google Scholar
• BanachMAronowWSHypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderlyJ Hum Hypertens2012261164164322513754
   PubMed Web of Science ®Google Scholar
• BeckettNSPetersRFletcherAEHYVET Study GroupTreatment of hypertension in patients 80 years of age or olderN Engl J Med2008358181887189818378519
   PubMed Web of Science ®Google Scholar
• Bejan-AngoulvantTSaadatian-ElahiMWrightJMTreatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trialsJ Hypertens20102871366137220574244
   PubMed Web of Science ®Google Scholar
• ReboldiGGentileGAngeliFVerdecchiaPBlood pressure lowering in the oldest oldJ Hypertens20102871373137620574245
   PubMed Web of Science ®Google Scholar
• BanachMAronowWSBlood pressure j-curve: current conceptsCurr Hypertens Rep201214655656623054894
   PubMed Web of Science ®Google Scholar
• PanjrathGSChaudhariSMesserliFHThe j-point phenomenon in aggressive therapy of hypertension: new insightsCurr Atheroscler Rep201214212412922396196
   PubMed Web of Science ®Google Scholar
• ChrysantSGCurrent status of aggressive blood pressure controlWorld J Cardiol201133657121499494
   PubMedGoogle Scholar
• PepineCJHandbergEMCooper-DeHoffRMINVEST InvestigatorsA calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialJAMA2003290212805281614657064
   PubMed Web of Science ®Google Scholar
• DenardoSJGongYNicholsWWBlood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudyAm J Med2010123871972620670726
   PubMed Web of Science ®Google Scholar
• OgiharaTMatsuokaHRakugiHPractitioner’s trial on the efficacy of antihypertensive treatment in elderly patients with hypertension II (PATE-hypertension II study) in JapanGeriatr Gerontol Int201111441442121410854
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983519118175517629635947
   PubMed Web of Science ®Google Scholar
• Wake Forest Baptist HospitalSystolic Blood Pressure Intervention Trial (SPRINT) Available form: http://clinicaltrials.gov/ct2/show/NCT1206062 NLM identifier: NCT1206062Accessed November 2, 2013
   Google Scholar
• Istituto Auxologico ItalianoEuropean Society of Hypertension and Chinese Hypertension League Stroke in Hypertension Optimal Treatment Trial (ESH-CHL-SHOT) Available from: http://clinicaltrials.gov/ct2/show/NCT1563731. NLM identifier: NCT1563731Accessed November 2, 2013
   Google Scholar
• O’BrienEParatiGStergiouGEuropean Society of Hypertension Working Group on Blood Pressure MonitoringEuropean society of hypertension position paper on ambulatory blood pressure monitoringJ Hypertens20133191731176824029863
   PubMed Web of Science ®Google Scholar
• SatoIAkazawaMPolypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database studyDrug Healthc Patient Saf2013514315023843704
   PubMedGoogle Scholar
• LawMRMorrisJKWaldNJUse of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ2009338b166519454737
   PubMed Web of Science ®Google Scholar
• OpiyoNShepperdSMusilaNEnglishMFretheimAThe “Child Health Evidence Week” and GRADE grid may aid transparency in the deliberative process of guideline developmentJ Clin Epidemiol201265996296922742914
   PubMed Web of Science ®Google Scholar
• TurnbullFNealBNinomiyaTBlood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trialsBMJ200833676531121112318480116
   PubMed Web of Science ®Google Scholar
• KjeldsenSEWeberMOparilSJamersonKACombining RAAS and calcium channel blockade: ACCOMPLISH in perspectiveBlood Press2008175–626026919061055
   PubMed Web of Science ®Google Scholar
• DuarteJDCooper-DeHoffRMMechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diureticsExpert Rev Cardiovasc Ther20108679380220528637
   PubMedGoogle Scholar
• DhallaIAGomesTYaoZChlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort studyAnn Intern Med2013158644745523552325
   PubMed Web of Science ®Google Scholar
• WehlingMMorbus diureticus in the elderly: epidemic overuse of a widely applied group of drugsJ Am Med Dir Assoc201314643744223510827
   PubMed Web of Science ®Google Scholar
• De CaterinaARLeoneAMWhy beta-blockers should not be used as first choice in uncomplicated hypertensionAm J Cardiol2010105101433143820451690
   PubMed Web of Science ®Google Scholar
• MesserliFHGrossmanEGoldbourtUAre beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic reviewJAMA199827923190319079634263
   PubMed Web of Science ®Google Scholar
• FlegJLAronowWSFrishmanWHCardiovascular drug therapy in the elderly: benefits and challengesNat Rev Cardiol201181132820978470
   PubMed Web of Science ®Google Scholar
• WiysongeCSBradleyHAVolminkJMayosiBMMbewuAOpieLHBeta-blockers for hypertension [review]Cochrane Database Syst Rev201211CD00200323152211
   PubMed Web of Science ®Google Scholar
• BangaloreSSawhneySMesserliFHRelation of beta-blocker-induced heart rate lowering and cardioprotection in hypertensionJ Am Coll Cardiol200852181482148919017516
   PubMed Web of Science ®Google Scholar
• CostanzoPPerrone-FilardiPPetrettaMCalcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patientsJ Hypertens20092761136115119451836
   PubMed Web of Science ®Google Scholar
• CocaAHypertension and vascular dementia in the elderly: the potential role of anti-hypertensive agentsCurr Med Res Opin20132991045105423745517
   PubMed Web of Science ®Google Scholar
• WangJGStaessenJALiYCarotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trialsStroke20063771933194016763185
   PubMed Web of Science ®Google Scholar
• WilliamsBLacyPSThomSMCAFE InvestigatorsAnglo-Scandinavian Cardiac Outcomes Trial InvestigatorsCAFE Steering Committee and Writing CommitteeDifferential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) studyCirculation200611391213122516476843
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLACCOMPLISH Trial InvestigatorsBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med2008359232417242819052124
   PubMed Web of Science ®Google Scholar
• ChenGJYangMSThe effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trialsPLoS One201383e5785423483932
   PubMed Web of Science ®Google Scholar
• COLM Study Research OrganizationCombination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study) Available from: http://clinicaltrials.gov/show/NCT0454662. NLM identifier: NCT0454662Accessed November 2, 2013
   Google Scholar
• MeurinPThe ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertensionAm J Cardiovasc Drugs20066532733417083267
   PubMedGoogle Scholar
• HanssonLLindholmLHEkbomTRandomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 studyLancet199935491921751175610577635
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJBoschJDaviesRDagenaisGEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med2000342314515310639539
   PubMed Web of Science ®Google Scholar
• GoschMThe role of ACE inhibitors in the treatment of hypertensive elderly patientsZ Gerontol Geriatr200033643343711201013
   PubMed Web of Science ®Google Scholar
• FretheimAOdgaard-JensenJBrørsOComparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysisBMC Med2012103322480336
   PubMed Web of Science ®Google Scholar
• FretheimAWitterSLindahlAKOlsenITPerformance-based financing in low- and middle-income countries: still more questions than answersBull World Health Organ2012908559559A22893735
   PubMed Web of Science ®Google Scholar
• PappoeLSWinkelmayerWCACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized?Drugs Aging2010272879420104936
   PubMed Web of Science ®Google Scholar
• Levi MarpillatNMacquin-MavierITropeanoAIBachoud-LeviACMaisonPAntihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysisJ Hypertens20133161073108223552124
   PubMed Web of Science ®Google Scholar
• WeirMRRolfeMPotassium homeostasis and renin-angiotensin-aldosterone system inhibitorsClin J Am Soc Nephrol20105353154820150448
   PubMed Web of Science ®Google Scholar
• DahlöfBDevereuxRde FaireUThe Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study GroupAm J Hypertens1997107 Pt 17057139234823
   PubMed Web of Science ®Google Scholar
• MannJJuliusSThe Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and designBlood Press1998731761839758088
   PubMedGoogle Scholar
• LithellHHanssonLSkoogISCOPE Study GroupThe Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trialJ Hypertens200321587588612714861
   PubMed Web of Science ®Google Scholar
• BoulangerJMHillMDMorbidity and mortality after stroke--eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)Stroke2006372335356 author reply 33816397169
   PubMed Web of Science ®Google Scholar
• CareyRMLoganAGAcute candesartan cilexetil therapy in stroke survivorsCurr Hypertens Rep20046211411615010014
   PubMed Web of Science ®Google Scholar
• CohnJNTognoniGValsartan Heart Failure Trial InvestigatorsA randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failureN Engl J Med2001345231667167511759645
   PubMed Web of Science ®Google Scholar
• SwedbergKPfefferMGrangerCCandesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme InvestigatorsJ Card Fail19995327628210496201
   PubMedGoogle Scholar
• MakaniHBangaloreSDesouzaKAShahAMesserliFHEfficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trialsBMJ2013346f36023358488
   PubMed Web of Science ®Google Scholar
• van VarkLCBertrandMAkkerhuisKMAngiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patientsEur Heart J201233162088209722511654
   PubMed Web of Science ®Google Scholar
• VerdecchiaPCalvoCMöckelVKeelingLSatlinASafety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertensionBlood Press200716638139118058456
   PubMed Web of Science ®Google Scholar
• DuprezDAMungerMABothaJKeefeDLCharneyANAliskiren for geriatric lowering of systolic hypertension: a randomized controlled trialJ Hum Hypertens201024960060820033075
   PubMed Web of Science ®Google Scholar
• FriedrichSSchmiederREReview of direct renin inhibition by aliskirenJ Renin Angiotensin Aldosterone Syst201314319319623873285
   PubMed Web of Science ®Google Scholar
• McMurrayJJAbrahamWTDicksteinKKøberLMassieBMKrumHAliskiren, ALTITUDE, and the implications for ATMOSPHEREEur J Heart Fail201214434134322431404
   PubMed Web of Science ®Google Scholar
• KrumHMassieBAbrahamWTATMOSPHERE InvestigatorsDirect renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) studyEur J Heart Fail201113110711421169387
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA2002288232981299712479763
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczKTask Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20133171281135723817082
   PubMed Web of Science ®Google Scholar
• VermeerSELongstrethWTKoudstaalPJSilent brain infarcts: a systematic reviewLancet Neurol20076761161917582361
   PubMed Web of Science ®Google Scholar
• NinomiyaTOharaTHirakawaYMidlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama studyHypertension2011581222821555680
   PubMed Web of Science ®Google Scholar
• FletcherAEBulpittCJHow far should blood pressure be lowered?N Engl J Med199232642512541727978
   PubMed Web of Science ®Google Scholar
• RománGCTatemichiTKErkinjunttiTVascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International WorkshopNeurology19934322502608094895
   PubMed Web of Science ®Google Scholar
• ChaudhryKNChavezPGasowskiJGrodzickiTMesserliFHHypertension in the elderly: some practical considerationsCleve Clin J Med2012791069470423027728
   PubMed Web of Science ®Google Scholar
• AlpérovitchABlachierMSoumaréABlood pressure variability and risk of dementia in an elderly cohort, the Three-City StudyAlzheimers Dement Epub2013814
   Web of Science ®Google Scholar
• MorrisMCScherrPAHebertLEAssociation between blood pressure and cognitive function in a biracial community population of older personsNeuroepidemiology200221312313012006775
   PubMed Web of Science ®Google Scholar
• RatnasabapathyYLawesCMAndersonCSThe Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular diseaseDrugs Aging200320424125112641480
   PubMed Web of Science ®Google Scholar
• YamadaKHoritaTTakayamaMEffect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion ratsBrain Res2011142111012021981801
   PubMed Web of Science ®Google Scholar
• KishiTHirookaYSunagawaKTelmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failureAm J Hypertens201427226026724096926
   PubMed Web of Science ®Google Scholar
• GelberRPRossGWPetrovitchHMasakiKHLaunerLJWhiteLRAntihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging StudyNeurology2013811088889523911753
   PubMed Web of Science ®Google Scholar
• WatfaGRossignolPKearney-SchwartzAUse of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaintsJ Hypertens201028122485249320739903
   PubMed Web of Science ®Google Scholar
• DenkerMGCohenDLWhat is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendationsClin Interv Aging201381505151724255596
   PubMed Web of Science ®Google Scholar
• BauerJHAge-related changes in the renin-aldosterone system. Physiological effects and clinical implicationsDrugs Aging1993332382458324299
   PubMed Web of Science ®Google Scholar
• MonaneMBohnRLGurwitzJHGlynnRJLevinRAvornJCompliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and raceAm J Public Health19968612180518089003143
   PubMed Web of Science ®Google Scholar
• ThoenesMSpirkDBöhmMMahfoudFThevathasanLBramlagePTreatment of hypertension in the elderly: data from an international cohort of hypertensives treated by cardiologistsJ Hum Hypertens201327213113722258208
   PubMed Web of Science ®Google Scholar
• WangPSAvornJBrookhartMAEffects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensivesHypertension200546227327915983239
   PubMed Web of Science ®Google Scholar
• ChrostowskaMNarkiewiczKImproving patient compliance with hypertension treatment: mission possible?Curr Vasc Pharmacol20108680480720626345
   PubMed Web of Science ®Google Scholar
• LaFleurJOderdaGMMethods to measure patient compliance with medication regimensJ Pain Palliat Care Pharmacother2004183818715364635
   PubMedGoogle Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
   PubMed Web of Science ®Google Scholar
• SherrillBHalpernMKhanSZhangJPanjabiSSingle-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherenceJ Clin Hypertens (Greenwich)2011131289890922142349
   PubMed Web of Science ®Google Scholar
• HillemanDERyschonKLMohiuddinSMWurdemanRLFixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluationJ Hum Hypertens199913747748310449213
   PubMed Web of Science ®Google Scholar
• MesserliFHOparilSFengZComparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertensionAm J Cardiol200086111182118711090788
   PubMed Web of Science ®Google Scholar
• HermannRRauMMarxCWolfGArterial hypertension: guideline acceptance and implementation in workaday life of internists and general practitioners in ThuringiaDtsch Med Wochenschr201313825–2613471352 German23761056
   PubMed Web of Science ®Google Scholar
• RizzoJASimonsWRVariations in compliance among hypertensive patients by drug class: implications for health care costsClin Ther199719614461457 discussion 1424–14259444452
   PubMed Web of Science ®Google Scholar
• HoltEJoyceCDornellesASex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adultsJ Am Geriatr Soc201361455856423528003
   PubMed Web of Science ®Google Scholar
• ChowdhuryEKOwenAKrumHSecond Australian National Blood Pressure Study Management Committee. Barriers to achieving blood pressure treatment targets in elderly hypertensive individualsJ Hum Hypertens201327954555123448846
   PubMed Web of Science ®Google Scholar
• VolpeMBattistoniATocciGCardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markersJ Hypertens20123061056106422573072
   PubMed Web of Science ®Google Scholar
• EggersKMVengePUtility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalitiesPathology201244212913822198250
   PubMed Web of Science ®Google Scholar
• SchäferHHScheunertUCosts of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary careSwiss Med Wkly2013143w1385424163048
   PubMedGoogle Scholar
• BramlagePHasfordJBlood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a reviewCardiovasc Diabetol200981819327149
   PubMed Web of Science ®Google Scholar
• AmbrosioniEPharmacoeconomic challenges in disease management of hypertensionJ Hypertens Suppl2001193S33S4011713849
   PubMedGoogle Scholar
• SchäferHHde VilliersJDSudanoIManagement of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary careInt J Clin Pract201266111125112623067037
   PubMed Web of Science ®Google Scholar
• RochefortCMMorlecJTamblynRMWhat differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative studyBMC Fam Pract201213922375684
   PubMed Web of Science ®Google Scholar
• GrimmCKöberleinJWiosnaWKresimonJKienckePRychlikRNew-onset diabetes and antihypertensive treatmentGMS Health Technol Assess20106 Doc03
   Google Scholar